Skip to content

Evaluation of Fluoxetine efficacy on change to side effect of ischemic strokes

Evaluation of Fluoxetine and standard treatment efficacy on change to side effect of stroke of ischemic strokes in both hemisphers in anterior circulation

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017041720258N37
Enrollment
60
Registered
2017-10-11
Start date
2017-02-18
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic strokes. Cerebellar stroke syndrome

Interventions

Intervention 1: We will prescribe patients ?one capsule of 20 milligram Fluoxetine ( Abidi drugs)and ?standard treatment ( drugs of Anti platelet and anticoagulant and Statin) in intervention group
Treatment - Drugs
We will prescribe patients ?one capsule of 20 milligram Fluoxetine ( Abidi drugs)and ?standard treatment ( drugs of Anti platelet and anticoagulant and Statin) in intervention group .
We will treatment patients ?standard treatment ( drugs of Anti platelet and anticoagulant and Statin) and ?placebo in control group.

Sponsors

Vice chancellor for research, Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: 40-70 years; both of gender; lack of history ischemic strokes and nerve focal defect in last; nerve focal defect in recent ischemic strokes; compatibility clinical symptoms of stroke and place conflict brain imaging; select patient in 2-7 days after start ischemic strokes Exclusion criteria: unavailability of patient during study period; history of side effect of Fluoxetine and other anti psychotic drugs; pregnant woman; lactating women; depression and recent depression in one month ago and treatment with anti psychotic drugs; use Monoamine oxidase inhibitorin five months ago

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Change to side effect of stroke. Timepoint: start study and first one and two months after treatment?. Method of measurement: National Institutes of Health Stroke Scale questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Keyvan Ghasami

Arak University of Medical Sciences

ghasami@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026